• Revenue up 8% at $398 million with higher proportion of reimbursable revenues
  • Technical utilization of 97% and economic utilization of 93% 
  • Operating Loss of $93 million
  • Adjusted EBITDA of $39 million, in line with guidance of $40 million 
  • Net loss of $199 million equivalent to net loss per share of $1.99
  • Strong order intake of $1.0 billion, resulting in total backlog of $2.5 billion at year end. 
  • Closing cash of $1.4 billion

We use cookies to make this website work better for you and to track site visits anonymously.
You can opt out if you like.